Arvinas ARVN
NASDAQ ARVN
$9.44 +0.13 (+1.40%)
As of: Sep 4, 2026 · 1:40 PM EDT

Arvinas (ARVN) Amortizatization of Intangibles (2017 - 2026)

Arvinas (ARVN) posted quarterly Amortizatization of Intangibles of $1.7 million for Q1 2026, down 55.26% year-over-year from $3.8 million in Q1 2025, and down 29.17% quarter-over-quarter from $2.4 million in Q4 2025.

Analysis

Arvinas (ARVN) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends

Arvinas' Amortizatization of Intangibles history runs 10 years deep, the most recent figure standing at $1.7 million for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles fell 55.26% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $10.7 million (down 46.77% YoY), while the FY2025 annual figure was $12.8 million, down 41.28% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $1.7 million, down from $2.4 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $5.9 million in Q3 2024, with the low at -$3.3 million in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $3.5 million (2025), against an average of $2.8 million.
  • The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles tumbled 230.0% in 2022, then jumped 757.14% in 2023.
  • Arvinas' Amortizatization of Intangibles stood at $800000.0 in 2022, then surged by 525.0% to $5.0 million in 2023, then retreated by 6.0% to $4.7 million in 2024, then tumbled by 48.94% to $2.4 million in 2025, then declined by 29.17% to $1.7 million in 2026.
  • Business Quant data shows ARVN's Amortizatization of Intangibles at $1.7 million in Q1 2026, $2.4 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.26 Bn 131.41 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.64 Bn 77.64 Bn 3.93 Bn -
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -
4 Moderna 57.83 Bn 52.69 Bn 52.00 Mn -
5 Revolution Medicines 44.08 Bn 44.08 Bn - 4.33 Mn
6 BeOne Medicines 39.94 Bn 34.84 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.19 Bn 31.88 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.35 Bn 26.19 Bn 358.27 Mn 678,000.00
10 Arvinas 611.71 Mn 43.81 Mn - 1.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.50 Mn
Mar 31, 2026 1.70 Mn
Dec 31, 2025 2.40 Mn
Sep 30, 2025 3.10 Mn
Jun 30, 2025 3.50 Mn
Mar 31, 2025 3.80 Mn
Dec 31, 2024 4.70 Mn
Sep 30, 2024 5.90 Mn
Jun 30, 2024 5.70 Mn
Mar 31, 2024 5.50 Mn
Dec 31, 2023 5.00 Mn
Sep 30, 2023 4.60 Mn
Jun 30, 2023 3.60 Mn
Mar 31, 2023 3.40 Mn
Dec 31, 2022 800,000.00
Sep 30, 2022 -700,000.00
Jun 30, 2022 -2.50 Mn
Mar 31, 2022 -3.30 Mn
Dec 31, 2021 -4.20 Mn
Sep 30, 2021 -2.50 Mn